| __timestamp | Exelixis, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 189101000 | 31354781 |
| Thursday, January 1, 2015 | 96351000 | 43445817 |
| Friday, January 1, 2016 | 95967000 | 66489820 |
| Sunday, January 1, 2017 | 112171000 | 96886134 |
| Monday, January 1, 2018 | 182257000 | 153793000 |
| Tuesday, January 1, 2019 | 336964000 | 148369000 |
| Wednesday, January 1, 2020 | 547851000 | 151934000 |
| Friday, January 1, 2021 | 693716000 | 198532000 |
| Saturday, January 1, 2022 | 891813000 | 112128000 |
| Sunday, January 1, 2023 | 1044071000 | 76192000 |
| Monday, January 1, 2024 | 910408000 |
Unleashing insights
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Exelixis, Inc. and TG Therapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) to drive breakthroughs. From 2014 to 2023, Exelixis has consistently outpaced TG Therapeutics in R&D spending, with a staggering 450% increase, peaking at over $1 billion in 2023. In contrast, TG Therapeutics saw a more modest growth, with R&D expenses rising by approximately 140% over the same period. This disparity highlights Exelixis's aggressive strategy to lead in innovation, while TG Therapeutics adopts a more measured approach. As the biotech landscape evolves, these investment trends could shape the future of medical advancements and market leadership.
AstraZeneca PLC or Exelixis, Inc.: Who Invests More in Innovation?
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
United Therapeutics Corporation vs Exelixis, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Exelixis, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Exelixis, Inc.
Analyzing R&D Budgets: Exelixis, Inc. vs Madrigal Pharmaceuticals, Inc.
Research and Development Investment: Exelixis, Inc. vs Alpine Immune Sciences, Inc.
Exelixis, Inc. or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Exelixis, Inc. vs Viridian Therapeutics, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs TG Therapeutics, Inc.
R&D Insights: How TG Therapeutics, Inc. and Xenon Pharmaceuticals Inc. Allocate Funds